<DOC>
	<DOCNO>NCT00387010</DOCNO>
	<brief_summary>The primary purpose study evaluate impact treatment fentanyl buccal tablet anxiety symptom commonly associate chronic pain patient breakthrough pain ( BTP ) . Other purpose assess management BTP , evaluate patient functioning , determine influence successful dose achieve .</brief_summary>
	<brief_title>Open-Label Study Evaluate Effect Treatment With Fentanyl Buccal Tablets Pain Anxiety Symptoms When Used Management Breakthrough Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Breakthrough Pain</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>The patient willing provide write informed consent participate study . The patient 18 80 year age . Women must surgically sterile , 2 year postmenopausal , , childbearing potential , use medically accept method birth control ( i.e. , barrier method spermicide , steroidal contraceptive [ oral , transdermal , implanted , injected contraceptive must use conjunction barrier method ] , intrauterine device [ IUD ] ) agree continue use method duration study . The patient chronic pain least 3 month duration associate following condition : cancer , diabetic peripheral neuropathy , postherpetic neuralgia , traumatic injury , complex regional pain syndrome , back pain , neck pain , fibromyalgia ( patient meet diagnostic criterion ) , chronic pancreatitis , osteoarthritis . Other chronic painful condition may evaluate entry upon discussion write approval Cephalon medical expert . The patient currently use 1 follow : least 60 mg oral morphine/day , least 25 mcg transdermal fentanyl/hour , least 30 mg oxycodone/day , least 8 mg hydromorphone/day , equianalgesic dose another opioid/day stable dose aroundtheclock ( ATC ) therapy least 7 day prior enrollment study . The patient report average pain intensity score , prior 24 hour , 6 less ( 0=no pain 10=worst pain ) chronic pain . The patient experience , average , 1 4 BTP episode per day take aroundtheclock ( ATC ) opioid therapy , average , duration breakthrough pain ( BTP ) episode le 3 hour . The patient currently use opioid therapy alleviation BTP episodes occur location chronic pain , achieve least partial relief . The patient must willing able successfully selfadminister study drug , comply study restriction , return clinic schedule study visit followup evaluation specify protocol . The patient uncontrolled rapidly escalate pain determine investigator ( ie , ATC therapy may expect change first last treatment study drug ) , pain uncontrolled therapy could adversely impact safety patient could compromise treatment study drug . The patient know suspected hypersensitivity , allergy , contraindication ingredient study drug . The patient recent history ( within 5 year ) current evidence alcohol substance abuse . The patient cardiopulmonary disease , opinion investigator , would significantly increase risk treatment potent synthetic opioids . The patient medical psychiatric disease , opinion investigator , would compromise collect data . The patient 's primary painful condition headache , include migraine . The patient expect surgery study , anticipate surgery alleviate patient 's pain . The patient therapy study drug treatment , opinion investigator , could alter pain response pain medication . The patient pregnant lactating . The patient participate previous study fentanyl buccal tablet . The patient participate study involve investigational drug previous 30 day . The patient receive monoamine oxidase inhibitor ( MAOI ) within 14 day first treatment study drug . The patient medical condition receive concomitant medication/therapy ( e.g. , regional nerve block ) , opinion investigator , would compromise patient 's safety compliance study protocol , compromise collect data . The patient involve active litigation regard chronic pain currently treat . The patient positive urine drug screen ( UDS ) illicit substance medication legitimately prescribed patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>